|
Index of reports
> Cases resulting in life threatening events (54)
Below is the selection of adverse event reports related to Taxol (Paclitaxel) that includes cases resulting in life threatening events.
Reports 1 - 25 of 54 Next >>
Adverse event in 65 year old female receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-10-24
Patient: 65 year old female, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol
Indication: Breast Cancer
Start date: 2007-09-11
Epirubicin
Indication: Breast Cancer
Start date: 2007-07-30
End date: 2007-08-28
Other drugs received by patient: Zolpidem Tartrate; Neorecormon; Neulasta
Adverse event in 26 year old female receiving Taxol (Paclitaxel)
Reported by a physician from Italy on 2007-10-23
Patient: 26 year old female, weighing 68.0 kg (149.6 pounds)
Adverse reactions / side effects: Dyspnoea, Anaphylactic Reaction, Tachycardia, Hyperhidrosis, Abdominal Pain Upper
Adverse event resulted in: life threatening event
Suspect drug(s):
Taxol
Dosage: 140mg weekly
Indication: Breast Cancer
Start date: 2007-07-20
End date: 2007-07-20
Trastuzumab
Indication: Breast Cancer
Other drugs received by patient: Vinorelbine
Adverse event in receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-23
Patient:
Adverse reactions / side effects: Haemoglobin Decreased, Atelectasis, Haematocrit Decreased, Dyspnoea, Pneumonia, Chest Pain, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Methadone HCL
Dosage: 10 mg, 1-2 tablet, q6hr
Administration route: Oral
Indication: Pain
Methadone HCL
Dosage: 40 mg, bid
Administration route: Oral
Start date: 2007-08-20
CP-751,871
Dosage: 1560 mg, single (1 dose q 21 days)
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-20
End date: 2007-06-20
CP-751,871
Dosage: 1600 mg, single (1 dose q 21 days)
Start date: 2007-07-11
End date: 2007-07-11
CP-751,871
Dosage: 1540 mg, single (1 dose q 21 days)
Start date: 2007-08-01
Taxol
Dosage: 395 mg, single (1 dose q 21 days)
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-19
End date: 2007-06-19
Taxol
Dosage: 382 mg, single (1 dose q 21 days)
Start date: 2007-07-10
End date: 2007-07-10
Taxol
Dosage: 329 mg, single (1 dose q 21 days)
Start date: 2007-07-31
End date: 2007-07-31
Carboplatin
Dosage: 620 mg, single (1 dose q 21 days)
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-19
End date: 2007-06-19
Carboplatin
Dosage: 564 mg, single ( 1 dose q 21 days)
Start date: 2007-07-10
End date: 2007-07-10
Carboplatin
Dosage: 516 mg, single (1 dose q 21 days)
Start date: 2007-07-31
Lexapro
Dosage: 10 mg, qd
Administration route: Oral
Start date: 2007-06-12
Coumadin
Dosage: 5 mg, qd
Administration route: Oral
Start date: 2007-07-31
Lovenox
Dosage: 10 mg, q6-8hr
Administration route: Oral
Start date: 2007-06-12
Other drugs received by patient: Reglan / 00041901 /; Nitroglycerin; Gabapentin; Oxycodone HCL
Adverse event in 40 year old female receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-18
Patient: 40 year old female
Adverse reactions / side effects: Fatigue, Anorexia, Myocardial Infarction
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol
Dosage: 6th cycle was started on 28-sep-oct.
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-01
End date: 2007-09-28
Paraplatin
Dosage: 6th cycle was started on 28-sep-2007
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-01
End date: 2007-09-28
Avastin
Dosage: 6th cycle was started on 27-sep-2007
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-01
End date: 2007-09-28
Adverse event in male receiving Taxol (Paclitaxel)
Reported by a physician from United Kingdom on 2007-10-16
Patient: male
Adverse reactions / side effects: Neutropenic Infection, Pneumonia, Chills, Muscular Weakness, Neutrophil Count Decreased, Disease Progression
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, q21d
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-01
Erbitux
Dosage: 250 mg/m2, 1/week
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-01
Taxol
Dosage: 200 mg/m2, q21d
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-01
Carboplatin
Dosage: unk, q21d
Indication: non-Small Cell Lung Cancer
Start date: 2007-05-01
Adverse event in male receiving Taxol (Paclitaxel)
Reported by a physician from United Kingdom on 2007-10-16
Patient: male
Adverse reactions / side effects: Thrombosis, Sudden Death
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Bevacizumab
Dosage: 15 mg/kg, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-13
End date: 2007-08-28
Cetuximab
Dosage: 250 mg/m2, 1/week
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-13
End date: 2007-08-28
Cetuximab
Dosage: 400 mg/m2, unk
Taxol
Dosage: 200 mg/m2, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-13
End date: 2007-08-28
Carboplatin
Dosage: 6 auc, q3w
Indication: non-Small Cell Lung Cancer
Start date: 2007-06-13
End date: 2007-08-28
Adverse event in 65 year old male receiving Taxol (Paclitaxel)
Reported by a consumer/non-health professional from Japan on 2007-10-11
Patient: 65 year old male
Adverse reactions / side effects: Pain in Extremity, Disease Progression, Haemoglobin Decreased, Cyanosis, Respiratory Failure, Depressed Level of Consciousness, Neutrophil Count Decreased, Renal Failure Acute
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Ifomide
Dosage: 1.3g iv 19-jul-2005 and continued
Indication: Prostate Cancer
Start date: 2005-06-21
Taxol
Dosage: 21-jun-2005 to 21-jun-2005; 19-jul-2005 to 19-jul-2005.
Indication: Prostate Cancer
Start date: 2005-06-21
End date: 2005-07-19
Aqupla
Dosage: 50mg iv on 19-jul-2005
Indication: Prostate Cancer
Start date: 2005-06-21
End date: 2005-07-19
Loxonin
Dosage: 20-jul-2005 to 28-jul-2005 and 27-jun-2005 to 29-jun-2005.
Administration route: Oral
Indication: Pain in Extremity
Start date: 2005-06-27
End date: 2005-07-28
Other drugs received by patient: Methotrexate; Doxorubicin HCL; Cisplatin; Vinblastine Sulfate; Cytotec
Adverse event in 71 year old female receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-10-09
Patient: 71 year old female
Adverse reactions / side effects: Interstitial Lung Disease
Adverse event resulted in: life threatening event
Suspect drug(s):
Taxol
Indication: Breast Cancer
Start date: 2007-03-01
End date: 2007-09-01
Goshajinkigan
Administration route: Oral
Start date: 2007-07-01
Adverse event in 70 year old female receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-10-08
Patient: 70 year old female
Adverse reactions / side effects: Hyperbilirubinaemia, Inappropriate Antidiuretic Hormone Secretion
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol
Indication: Ovarian Cancer
Start date: 2007-08-16
End date: 2007-08-16
Paraplatin
Indication: Ovarian Cancer
Start date: 2007-08-16
End date: 2007-08-16
Trichlormethiazide
Administration route: Oral
Other drugs received by patient: Kytril; Decadron; Restamin
Adverse event in female receiving Taxol (Paclitaxel)
Reported by a consumer/non-health professional from Netherlands on 2007-10-05
Patient: female, weighing 85.0 kg (187.0 pounds)
Adverse reactions / side effects: Renal Impairment, Pain in Extremity, Oedema Peripheral, Headache
Adverse event resulted in: life threatening event, disablity
Suspect drug(s):
Aranesp
Indication: Anaemia of Malignant Disease
Start date: 2007-05-10
Taxol
Start date: 2007-04-16
End date: 2007-06-18
Adverse event in 77 year old female receiving Taxol (Paclitaxel)
Reported by a pharmacist from France on 2007-10-03
Patient: 77 year old female, weighing 63.0 kg (138.6 pounds)
Adverse reactions / side effects: Bronchospasm, Respiratory Distress, Shock, Loss of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol (Paclitaxel)
Other drugs received by patient: Solu-Medrol; Zantac; Polaramine
Adverse event in 66 year old male receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from Japan on 2007-10-01
Patient: 66 year old male
Adverse reactions / side effects: Malaise, Malignant Neoplasm Progression, Anaemia, Febrile Neutropenia, Acute Respiratory Distress Syndrome
Adverse event resulted in: death, life threatening event, hospitalization
Suspect drug(s):
Taxol (Paclitaxel)
Other drugs received by patient: TS-1; Fluconazole
Adverse event in 59 year old female receiving Taxol (Paclitaxel)
Reported by a physician from Italy on 2007-07-27
Patient: 59 year old female
Adverse reactions / side effects: Tachycardia, DRY Mouth, Swollen Tongue, Abdominal Pain Upper
Adverse event resulted in: life threatening event
Suspect drug(s):
Taxol (Paclitaxel)
Adverse event in female receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-10
Patient: female, weighing 49.0 kg (107.8 pounds)
Adverse reactions / side effects: Chest Pain
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Bevacizumab
Dosage: 743 mg, q3w
Indication: Lung Neoplasm Malignant
Start date: 2007-02-16
Taxol
Dosage: 292 mg, unk
Indication: Lung Neoplasm Malignant
Start date: 2007-02-16
Carboplatin
Dosage: 352 mg, unk
Indication: Lung Neoplasm Malignant
Start date: 2007-02-16
Adverse event in 41 year old female receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from Germany on 2007-07-10
Patient: 41 year old female, weighing 76.0 kg (167.2 pounds)
Adverse reactions / side effects: Back Pain, Arthralgia
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Cyclophosphamide
Indication: Breast Cancer
Taxol
Indication: Breast Cancer
Start date: 2007-06-29
Epirubicin
Indication: Breast Cancer
Neulasta
Indication: Leukopenia
Start date: 2007-06-30
End date: 2007-06-30
Other drugs received by patient: Aranesp
Adverse event in 73 year old female receiving Taxol (Paclitaxel)
Reported by a physician from France on 2007-07-10
Patient: 73 year old female, weighing 57.0 kg (125.4 pounds)
Adverse reactions / side effects: Onycholysis, Intestinal Obstruction, Constipation
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol (Paclitaxel)
Adverse event in 78 year old male receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-07-06
Patient: 78 year old male
Adverse reactions / side effects: Urinary Incontinence, Tonic Convulsion, Altered State of Consciousness
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol (Paclitaxel)
Other drugs received by patient: Gemzar; Kytril; Decadron; Zantac
Adverse event in 50 year old male receiving Taxol (Paclitaxel)
Reported by a pharmacist from United States on 2007-07-06
Patient: 50 year old male, weighing 85.3 kg (187.6 pounds)
Adverse reactions / side effects: Back Pain, Flushing, Dyspnoea, Wheezing
Adverse event resulted in: life threatening event
Suspect drug(s):
Taxol (Paclitaxel)
Adverse event in 59 year old female receiving Taxol (Paclitaxel)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-26
Patient: 59 year old female, weighing 78.6 kg (172.9 pounds)
Adverse reactions / side effects: Back Pain, Pruritus, Dyspnoea, Chest Pain, Blood Pressure Decreased, Oxygen Saturation Decreased, Infusion Related Reaction
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol (Paclitaxel)
Adverse event in 83 year old female receiving Taxol (Paclitaxel)
Reported by a pharmacist from United States on 2007-06-20
Patient: 83 year old female
Adverse reactions / side effects: Cyanosis, Blood Pressure Decreased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol (Paclitaxel)
Adverse event in 66 year old female receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-06-19
Patient: 66 year old female
Adverse reactions / side effects: Lymphocyte Percentage Decreased, Neutrophil Percentage Increased, Refractory Anaemia, Malignant Neoplasm Progression, Myelodysplastic Syndrome, Metastasis, RED Blood Cell Count Decreased, Metastases TO Spleen, Monocyte Percentage Decreased, Injection Site Reaction, Platelet Count Decreased, Vasculitis, Salpingo-Oophorectomy Bilateral, White Blood Cell Count Increased
Adverse event resulted in: life threatening event
Suspect drug(s):
Taxol
Indication: Ovarian Cancer
Start date: 2003-01-01
End date: 2006-12-07
Paraplatin
Indication: Ovarian Cancer
Start date: 2003-01-01
End date: 2006-12-07
Adverse event in 66 year old female receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-06-15
Patient: 66 year old female
Adverse reactions / side effects: Malignant Neoplasm Progression, Myelodysplastic Syndrome, Vasculitis
Adverse event resulted in: life threatening event
Suspect drug(s):
Taxol
Indication: Ovarian Cancer
Start date: 2003-01-01
End date: 2006-12-07
Paraplatin
Indication: Ovarian Cancer
Start date: 2003-01-01
End date: 2006-12-07
Adverse event in female receiving Taxol (Paclitaxel)
Reported by a physician from United States on 2007-06-13
Patient: female, weighing 54.4 kg (119.7 pounds)
Adverse reactions / side effects: Adverse Drug Reaction, Pulse Absent, Circulatory Collapse, Coma, Pulmonary Embolism, Feeling Abnormal, Apnoea
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Taxol (Paclitaxel)
Adverse event in 66 year old female receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-06-08
Patient: 66 year old female
Adverse reactions / side effects: Malignant Neoplasm Progression, Myelodysplastic Syndrome, Vasculitis
Adverse event resulted in: life threatening event
Suspect drug(s):
Taxol
Indication: Ovarian Cancer
Start date: 2003-01-01
End date: 2006-12-07
Paraplatin
Indication: Ovarian Cancer
Start date: 2003-01-01
End date: 2006-12-07
Adverse event in 75 year old male receiving Taxol (Paclitaxel)
Reported by a physician from Japan on 2007-05-31
Patient: 75 year old male
Adverse reactions / side effects: Interstitial Lung Disease, Rash
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Taxol
Indication: non-Small Cell Lung Cancer
Paraplatin
Indication: non-Small Cell Lung Cancer
Other drugs received by patient: Radiotherapy
Page 1 Next >>
|
